Calcium supplementation attenuates citrate-related changes in bone metabolism: A placebo-controlled crossover study in healthy volunteers

Bone

Volumn 49, Issue 3, 2011, Pages 506-512

  Chen, Ying ^a   Hou, Jianming ^b   Chen, Guolong ^a   Lin, Hao ^a   Lin, Hongkeng ^a   Chu, Xiaoling ^a   Zeng, Jia ^a   Chen, Cen ^a   Lin, Juan ^b   Dettke, Markus ^c  

^a Fujian Blood Center   (China)

^b FUJIAN PROVINCIAL HOSPITAL   (China)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Apheresis; Bone marker; Calcium supplementation; Citrate anticoagulation; Healthy volunteer

Indexed keywords

CALCIUM; CALCIUM CARBONATE; CARBOXY TERMINAL TELOPEPTIDE; CITRIC ACID; GLUCONATE CALCIUM; OSTEOCALCIN; PARATHYROID HORMONE; PLACEBO;

ADULT; APHERESIS; ARTICLE; BLOOD SAMPLING; BONE METABOLISM; BONE REMODELING; BONE TURNOVER; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET SUPPLEMENTATION; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; OSSIFICATION; OSTEOLYSIS; VOLUNTEER;

ADULT; BIOLOGICAL MARKERS; BLOOD COMPONENT REMOVAL; BONE AND BONES; BONE REMODELING; CALCIUM; CALCIUM CARBONATE; CALCIUM GLUCONATE; CITRIC ACID; COLLAGEN TYPE I; CROSS-OVER STUDIES; FEMALE; HUMANS; MALE; OSTEOCALCIN; PARATHYROID HORMONE; PEPTIDES; PLACEBOS;

EID: 79960595096     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2011.05.014     Document Type: Article

References (23)

1. Winters J.L. Complications of donor apheresis. J Clin Apher 2006, 21:132-141.
2. Mcleod B.C., Price T.H., Owen H., Ciavarella D., Sniecinski I., Randels M.J., et al. Frequency of immediate adverse effects associated with apheresis donation. Transfusion 1998, 38:938-943.
3. Bolan C.D., Greer S.E., Cecco S.A., Oblitas J.M., Rehak N.N., Leitman S.F. Comprehensive analysis of citrate effects during plateletpheresis in normal donors. Transfusion 2001, 41:1165-1171.
4. Bolan C.D., Cecco S.A., Yau Y.Y., Wesley R.A., Oblitas J.M., Rehak N.N., et al. Randomized placebo-controlled study of oral calcium carbonate supplementation in plateletpheresis: II. Metabolic effects. Transfusion 2003, 43:1414-1422.
5. Dettke M., Buchta C., Bieglmayer C., Kainberger F., Macher M., Hoecker P. Short and long term effects of citrate on bone metabolism and bone mineral density in healthy plateletpheresis donors (abstract). J Clin Apher 2003, 18:87.
6. Chen Y., Bieglmayer C., Höcker P., Dettke M. Effect of acute citrate load on markers of bone metabolism in healthy volunteers. Vox Sang 2009, 97:324-329.
7. Amrein K., Katschnig C., Sipurzynski S., Stojakovic T., Lanzer G., Stach E., et al. Apheresis affects bone and mineral metabolism. Bone 2010, 46:789-795.
8. Buchta C., Macher M., Bieglemayer C., Hoecker P., Dettke M. Reduction of adverse citrate reactions during autologous large volume PBPC apheresis by continuous infusion of calcium gluconate. Transfusion 2003, 43:1615-1621.
9. Guillemant J., Le H., Maria A., Guillemant S. Acute effects of oral calcium load on parathyroid function and on bone resorption in young men. Am J Nephrol 2000, 20:48-52.
10. Karp H.J., Ketola M.E., Lamberg-Allardt C.J. Acute effects of calcium carbonate, calcium citrate and potassium citrate on markers of calcium and bone metabolism in young women. Br J Nutr 2009, 102:1341-1347.
11. Zika'n V., Haas T., Stepan J.J. Acute effects in healthy women of oral calcium on the calcium-parathyroid axis and bone resorption as assessed by serum ß-crosslaps. Calcif Tissue Int 2001, 68:352-357.
12. Hannon R., Eastell R. Preanalytical variability of biochemical markers of bone turnover. Osteoporos Int 2000, 11(Suppl. 6):S30-S44.
13. Seibel M.J. Biochemical markers of bone turnover: part I: biochemistry and variability. Clin Biochem Rev 2005, 26:97-122.
14. Wichers M., Schmidt E., Bidlingmaier F. Diurnal rhythm of crosslaps in human serum. Clin Chem 1999, 45:1858-1860.
15. Gundberg C.M., Markowitz M.E., Mizruchi M., Rosen J.F. Osteocalcin in human serum: a circadian rhythm. J Clin Endocrinol Metab 1985, 4:736-739.
16. Nordin B.E. Assessment of calcium excretion from the urinary calcium/creatinine ratio. Lancet 1959, 2:368-371.
17. Bieglmayer C., Kudlacek S. The bone marker plot: an innovative method to assess bone turnover in women. Eur J Clin Invest 2009, 39:230-238.
18. Food and Drug Administration Center for Biologics Evaluation and Research, U.S.Department of Health and Human Services Guidance for industry and FDA review staff: collection of platelets by automated methods Retrieved January 17, 2011 from the world wide web:. http://www.fda.gov/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/Blood/ucm073382.htm.
19. UK Blood Transfusion & Tissues Transplantation Services Guidelines for the Blood transfusion services in the UK (7th edition: chapter 6) Retrieved January 17, 2011 from the world wide web:. http://www.transfusionguidelines.org.uk/index.aspx?Publication=RB.
20. Garnero P., Sornay-Rendu E., Duboeuf F., Delmas P.D. Markers of bone turnover predict postmenopausal forearm bone loss over 4 years: the OFELY study. J Bone Miner Res 1999, 14:1614-1621.
21. Srivastava A.K., Vliet E.L., Lewiecki E.M., Maricic M., Abdelmalek A., Gluck O., et al. Clinical use of serum and urine bone markers in the management of osteoporosis. Curr Med Res Opin 2005, 21:1015-1026.
22. Deroisy R., Zartarian M., Meurmans L., Nelissenne N., Micheletti M.C., Albert A., et al. Acute changes in serum calcium and parathyroid hormone circulating levels induced by the oral intake of five currently available calcium salts in healthy male volunteers. Clin Rheumatol 1997, 16:249-253.
23. Bolan C.D., Wesley R.A., Yau Y.Y., Cecco S.A., Starling J., Oblitas J.M., et al. Randomized placebo-controlled study of oral calcium carbonate administration in plateletpheresis: I. Associations with donor symptoms. Transfusion 2003, 43:1403-1413.